Not just insulin: Early increases in glucagon in type 2 diabetes are linked to fatty liver disease

AI Summary

Recent research from the German Diabetes Center indicates that early increases in glucagon levels in patients with type 2 diabetes are linked to the development of fatty liver disease. This new finding could have implications for diabetes management.

Until now, research into type 2 diabetes has focused primarily on insulin: if the body's cells become less responsive to the hormone produced in the pancreas, blood glucose levels rise over the long term. A recent study by the German Diabetes Center now shows that levels of the hormone glucagon are also elevated at an early stage. The paper is published in the journal Diabetes Care.